Abstract
1 alpha-Monofluoromethyldopa (MFMD, RMI 71963), a potent and selective enzyme-activated irreversible inhibitor of aromatic L-amino acid decarboxylase produces a substantial and long-lasting decrease in the catecholamine content of mouse brain, heart and kidney. 2 Single doses of MFMD reduce the 5-hydroxytryptamine concentration of mouse brain without altering the tryptophan concentration. 3 In animals treated with MFMD, peripheral but not brain noradrenaline is restored within 1 h to control levels by an intraperitoneal injection of dopamine.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bartholini G., Pletscher A. Decarboxylase inhibitors. Pharmacol Ther B. 1975;1(3):407–421. doi: 10.1016/0306-039x(75)90047-1. [DOI] [PubMed] [Google Scholar]
- Fozard J. R., Palfreyman M. G., Spedding M., Wagner J., Woodward J. K. Inhibition of peripheral sympathetic function by alpha-monofluoromethyldopa, an irreversible inhibitor of aromatic amino acid decarboxylase [proceedings]. Br J Pharmacol. 1979 Nov;67(3):461P–461P. [PMC free article] [PubMed] [Google Scholar]
- Jung M. J., Palfreyman M. G., Ribereau-Gayon G., Wagner J., Zraïka M. Monamine-depleting properties of a new and very potent enzyme-activated irreversible inhibitor of aromatic aminoacid decarboxylase: alpha-monofluoromethyldopa [proceedings]. Br J Pharmacol. 1979 Nov;67(3):460P–460P. [PMC free article] [PubMed] [Google Scholar]
- Jung M. J., Palfreyman M. G., Wagner J., Bey P., Ribereau-Gayon G., Zraïka M., Koch-Weser J. Inhibition of monoamine synthesis by irreversible blockade of aromatic aminoacid decarboxylase with alpha-monofluoromethyldopa. Life Sci. 1979 Mar 12;24(11):1037–1042. doi: 10.1016/0024-3205(79)90324-2. [DOI] [PubMed] [Google Scholar]
- Kollonitsch J., Perkins L. M., Patchett A. A., Doldouras G. A., Marburg S., Duggan D. E., Maycock A. L., Aster S. D. Selective inhibitors of biosynthesis of aminergic neurotransmitters. Nature. 1978 Aug 31;274(5674):906–908. doi: 10.1038/274906a0. [DOI] [PubMed] [Google Scholar]
- LEVITT M., SPECTOR S., SJOERDSMA A., UDENFRIEND S. ELUCIDATION OF THE RATE-LIMITING STEP IN NOREPINEPHRINE BIOSYNTHESIS IN THE PERFUSED GUINEA-PIG HEART. J Pharmacol Exp Ther. 1965 Apr;148:1–8. [PubMed] [Google Scholar]
- Palfreyman M. G., Danzin C., Bey P., Jung M. J., Ribereau-Gayon G., Aubry M., Vevert J. P., Sjoerdsma A. alpha-difluoromethyl DOPA, a new enzyme-activated irreversible inhibitor of aromatic L-amino acid decarboxylase. J Neurochem. 1978 Oct;31(4):927–932. doi: 10.1111/j.1471-4159.1978.tb00129.x. [DOI] [PubMed] [Google Scholar]
- Wagner J., Palfreyman M., Zraika M. Determination of dopa, dopamine, dopac, epinephrine, norepinephrine, alpha-monofluoromethyldopa and alpha-difluoromethyldopa in various tissues of mice and rats using reversed-phase ion-pair liquid chromatography with electrochemical detection. J Chromatogr. 1979 Sep 11;164(1):41–54. doi: 10.1016/s0378-4347(00)81570-4. [DOI] [PubMed] [Google Scholar]